An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry

Alimentary Pharmacology and Therapeutics

Volumn 21, Issue 1, 2005, Pages 29-34

  Zentilin, P ^a   Dulbecco, P ^a   Savarino, E ^a   Parodi, A ^a   Iiritano, E ^a   Bilardi, C ^a   Reglioni, S ^a   Vigneri, S ^b   Savarino, V ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; GAVISCON;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; COMBINED MULTICHANNEL INTRALUMINAL IMPEDANCE; DIET; DRUG EFFICACY; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; IMPEDANCE; IMPEDANCEMETRY; MALE; PH METRY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SUPINE POSITION; SYMPTOMATOLOGY;

ADULT; AGED; ALGINATES; ALUMINUM HYDROXIDE; ANTACIDS; DRUG COMBINATIONS; DRUG EVALUATION; FEMALE; GASTRIC ACID; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; SILICIC ACID; SODIUM BICARBONATE;

EID: 12944281058     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.02298.x     Document Type: Article

References (32)

1. Williams DL, Haigh GG, Redfern JN. The symptomatic treatment of heartburn and dyspepsia with Liquid Gaviscon®: a multicentre general practitioner study. J Int Med Res 1979; 7: 551-5.
2. Poynard T, Vernisse B. Agostini H for a Multicentre Group. Randomized, multicentre comparison of sodium alginate and cisapride in the symptomatic treatment of uncomplicated gastro-oesophageal reflux. Aliment Pharmacol Ther 1998; 12: 159-65.
3. Miller S. Comparison of the efficacy and safety of a new aluminium-free paediatric alginate preparation and placebo in infants with recurrent gastro-oesophageal reflux. Curr Med Res Opin 1999; 15: 160-8.
4. Buts JP, Barudi C, Otte JB. Double-blind controlled study on the efficacy of sodium alginate (Gaviscon®) in reducing gastroesophageal reflux assessed by 24-h continuous pH monitoring in infants and children. Eur J Pediatr 1987; 146: 156-8.
5. Mandel KG, Daggy BP, Brodie DA, Jacoby HI. Review article: Alginate-raft formulations in the treatment of heartburn and acid reflux. Aliment Pharmacol Ther 2000; 14: 669-90.
6. Lambert JR, Korman MG, Nicholson L, Chan JG. In-vivo anti-reflux and raft properties of alginates. Aliment Pharmacol Ther 1990; 4: 615-22.
7. Moss HA, Washington N, Greaves JL, Wilson CL. Anti-reflux agents, stratification or floatation? Eur J Gastroenterol Hepatol 1990; 2: 45-51.
8. Malmud LS, Charles ND, Littlefield J, et al. The mode of action of alginic acid compound in the reduction of gastro-oesophageal reflux. J Nucl Med 1979; 20: 1023-8.
9. Chatfield S. A comparison of the efficacy of the alginate preparation, Gaviscon Advance, with placebo in the treatment of gastro-oesophageal reflux disease. Curr Med Res Opin 1999; 15: 152-9.
10. Taylor G, Warren SJ, Kellaway IW, Patel B, Little SL. Gastric residence of Gaviscon Advance and Liquid Gaviscon in healthy volunteers. J Pharm Pharmacol 1997; 49: 73-9.
11. Castell DO, Dalton CB, Becker D, Sinclair J, Castell JA. Alginic acid decreases postprandial upright gastroesophageal reflux: comparison with equal-strength antacid. Dig Dis Sci 1992; 37: 589-93.
12. Johnson LF, DeMeester TR. Evaluation of elevation of the head of the bed, bethanechol, and antacid foam tablets on gastroesophageal reflux. Dig Dis Sci 1981; 26: 673-80.
13. Washington N, Steele RJC, Jackson J, Washington C, Bush D. Patterns of food and acid reflux in patients with low-grade oesophagitis - the role of anti-reflux agent. Aliment Pharmacol Ther 1998; 12: 53-8.
14. Tutuian R, Vela M, Shay SS, Castell DO. Multichannel intraluminal impedance in esophageal function testing and gastroesophageal reflux monitoring. J Clin Gastroenterol 2003; 37: 206-15.
15. Zentilin P, Dulbecco P, Savarino E, Giannini E, Savarino V. Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastro-oesophageal reflux. Literature review. Dig Liver Dis 2004; 36: 565-9.
16. Sifrim D, Holloway R, Silny J, et al. Acid, non-acid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings. Gastroenterology 2001; 120: 1588-98.
17. Sifrim D, Castell D, Dent J, Kahrilas PJ. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 2004; 53: 1024-31.
18. Vela MF, Camacho-Lobato L, Srinivasan R, Tutuian R, Katz PO, Castell D. Intraesophageal impedance and pH measurement of acid and non-acid reflux: effect of omeprazole. Gastroenterology 2001; 120: 1599-606.
19. Vela MF, Tutuian R, Katz PO, Castell D. Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH. Aliment Pharmacol Ther 2003; 17: 243-51.
20. Zhang X, Tack J, Janssens J, Sifrim D. Acid and non-acid gastroesophageal reflux after endoscopic gastroplication. Evaluation of the antireflux barrier function with 24-Hs-pH-impedance. Gastroenterology 2003; 124: A-97.
21. Khoury RM, Camacho-Lobato L, Katz PO, Mohiuddin MA, Castell DO. Influence of spontaneous sleep positions on nighttime recumbent reflux in patients with gastroesophageal reflux disease. Am J Gastroenterol 1999; 94: 2069-73.
22. van Herwaarden MA, Katzka DA, Smout AJPM, Samsom M, Gideon M, Castell DO. Effect of different recumbent positions on postprandial gastroesophageal reflux in normal subjects. Am J Gastroenterol 2000; 95: 2731-6.
23. Marciani L, Little SL, Snee J, et al. Echo-planar magnetic resonance imaging of Gaviscon alginate rafts in-vivo. J Pharm Pharmacol 2002; 54: 1351-6.
24. Washington N, Greaves JL, Iftikhar SY. A comparison of gastro-oesophageal reflux in volunteers assessed by ambulatory pH and gamma monitoring after treatment with either Liquid Gaviscon or Algicon suspension. Aliment Pharmacol Ther 1992; 6: 579-88.
25. Laitinen S, Stahlberg M, Kairaluoma MI, et al. Sucralfate and alginate/antacid in reflux esophagitis. Scand J Gastroenterol 1985; 20: 229-32.
26. LeLuyer B, Mougenot JF, Mashako L, et al. Multicenter study of sodium alginate in the treatment of regurgitation in infants. Ann Pediatr 1992; 39: 635-40.
27. Oderda G, Dell'Olio D, Forni M, Farina L, Tavassoli K, Ansaldi N. Treatment of childhood peptic oesophagitis with famotidine or alginate-antacid. Ital J Gastroenterol 1990; 22: 346-9.
28. Poynard T and a French Co-operative Study Group. Relapse rate of patients after healing of oesophagitis - a prospective study of alginate as self-care treatment for 6 months. Aliment Pharmacol Ther 1993; 7: 385-92.
29. Washington N, Wilson CG, Davis SS. Evaluation of 'raft-forming' antacid neutralizing capacity: in vitro and in vivo correlations. Int J Pharm 1985: 279-86.
30. Beely M, Warner JO. Medical treatment of symptomatic hiatus hernia with low density compounds. Curr Med Res Opin 1972; 1: 63-9.
31. Jailwala JA, Shaker R. Supre-oesophageal complications of reflux disease. Dig Liver Dis 2000; 32: 267-74.
32. Ramon P, Mallart-Voisin A, Wallaert B, et al. The association of asthma and gastroesophageal reflux: strategy of paraclinical studies. Rev Mal Respir 1985; 2: 289-94.